Autopsy report · NCT01868243
Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation Postoperatively
Cause of deathOther
“because a significant decrease of viable candidates for the study.”
Life of this trial
- Registered 3 months before it started.
- Ran for about 1 year 2 months before it stopped.
- 27 participants enrolled.
- Results were posted on the registry 1 year after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2, Phase 3
- Sponsor
- Hospital Ana Nery
- Sponsor type
- University, hospital or other
- Conditions
- Primary Disease
- Interventions
- Dabigatran; Warfarin
- Participants
- 27
- Sites
- 1
- Countries
- Brazil
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.